Can Stem Cell studies help treat Chronic Obstructive Pulmonary Disease (COPD)?
COPD clinical studies are being evaluated to determine stem cells’ role in improving COPD complications to perhaps help patients who do not respond to conventional drug treatment.
If you would like more information regarding stem cell COPD therapy at Next Generation Stem Cell, please call
Frequently asked Stem Cell COPD questions
What is COPD?
Chronic Obstructive Pulmonary (lung) Disease is a group of conditions in which the lungs are not able to completely expel air. The result is shortness of breath, fatigue and the feeling that one is unable to take a deep breath. Some of the conditions associated with COPD are chronic bronchitis, emphysema, bronchiectasis and others. Patients with some of the more severe cases need supplemental oxygen in order to breathe comfortably and to maintain a normal blood oxygen level.
How could stem cells help in COPD?
Next Generation Stem Cell is currently researching adipose stem therapy as it relates to the complications of COPD. Findings suggest that there is a possibility that the stem cells harvested from the patient themselves have the potential to replace damaged lung tissue cells. Not only can new cells be created, but there is potential to suppress the immune system’s response of engulfing and digesting the dying cells of the lungs. This can bring hope to so many patients with these debilitating and in some cases, degenerative conditions. The following is a list of improvements seen after Stem Cell COPD treatment:
- Reduction of dyspnea (difficult or labored breathing)
- Increased energy
- Increase in the ability to walk alone
- Increase in the ability to perform daily tasks
- Reduction of reliance on supplemental oxygen
- Improvements in sleep patterns
- Enhanced mood
How are stem cells for COPD therapy administered ?
Ways of administering stem cells for COPD include:
- Intravenous in which the stem cells are administered directly into the vein.
- Stem Cell Nebulization in which the stem cells are reduced into a fine mist and are inhaled by the patient and received directly into the lungs.